EBI-005-AC-1

· Eleven Biotherapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBI-005-AC-1, covering 2014-07-11 to 2014-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1) [Phase 2]